| Company Name | Exchange | Ticker | Last Price | Day 1 (% Change) | Day 2 (% Change) | 52 WEEK HIGH | 52 WEEK LOW | Last Volume | M.Cap MM ($) |
| Pernix Therapeutics Holdings | NASDAQ | PTX | 6.43 | 30.6% | 15.0% | 6.66 | 1.68 | 6,025,287 | 242.9 |
| Rexahn Pharmaceuticals Inc | NYSE | RNN | 1.03 | 51.8% | 14.7% | 1.85 | 0.31 | 15,612,375 | 183.3 |
These two U.S. biotechnology stocks are featured as top stocks of the day based on their price performance during previous trading sessions. These stocks recorded a strong price gain momentum during the past two trading session with significant volumes.
Pernix Therapeutics Holdings (NASDAQ: PTX), a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas, gained more than 50% during its past two trading sessions gaining more than 15% in each of the two consecutive days. During its last trading session, the stock powered 15% higher closing at $6.43 with significant trading volumes of 6.0 million shares. During its past 5-trading sessions, PTX surged 48.2% with 5-day average volume of 2.8 million shares compared to 1-month daily average volume of 722,270 shares.
Rexahn Pharmaceuticals Inc (NYSE: RNN), a development-stage biopharmaceutical company focused on the development of cures for cancer to patients, jumped more than 30% during its past two trading sessions climbing more than 14% in each of the two consecutive days. During its last trading session, the stock powered 14.7% higher closing at $1.03 with significant trading volumes of 15.6 million shares. During its past 5-trading sessions, RNN surged 28.4% with 5-day average volume of 4.4 million shares compared to 1-month daily average volume of 4.2 million shares.
